DexCom, Inc. DXCM
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.76% | 9.77% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.76% | 9.77% | |||
| Cost of Revenue | 0.36% | 8.33% | |||
| Gross Profit | 4.14% | 10.62% | |||
| SG&A Expenses | 4.71% | 2.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.75% | 5.71% | |||
| Operating Income | 2.80% | 24.68% | |||
| Income Before Tax | 5.42% | 17.81% | |||
| Income Tax Expenses | -12.87% | -2.29% | |||
| Earnings from Continuing Operations | 10.44% | 24.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.44% | 24.86% | |||
| EBIT | 2.80% | 24.68% | |||
| EBITDA | 3.93% | 19.88% | |||
| EPS Basic | 12.64% | 25.83% | |||
| Normalized Basic EPS | 4.24% | 22.45% | |||
| EPS Diluted | 12.23% | 25.84% | |||
| Normalized Diluted EPS | 3.96% | 22.62% | |||
| Average Basic Shares Outstanding | -1.96% | -0.75% | |||
| Average Diluted Shares Outstanding | -1.69% | -0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||